Zacks Industry Outlook UnitedHealth, The Cigna, Humana, Centene and Molina
UnitedHealth, The Cigna, Humana, Centene and Molina have been highlighted in this Industry Outlook article.
UnitedHealth, The Cigna, Humana, Centene and Molina have been highlighted in this Industry Outlook article.
An aging U.S. population, digital transformation, a diversified membership mix and strategic M&A are likely to drive the performance of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.
BAY CITY, Mich.--(BUSINESS WIRE)--Molina Healthcare of Michigan donates $85,000 to support two organizations addressing hunger and housing in Bay and Saginaw counties.
Molina (MOH) reported earnings 30 days ago. What's next for the stock?
SAGINAW, Mich.--(BUSINESS WIRE)--The MolinaCares Accord and Molina Healthcare of Michigan donate $100,000 to support construction of a new food kitchen in Saginaw County.
Concentra (NYSE: CON), the nation's leader in occupational and workforce health services, today announced completion of its acquisition of four Minnesota Occu
Michael Burry (Trades, Portfolio) has increased his stake in Molina Healthcare (MOH), pointing to longer-term confidence in the health insurer and a potential p
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina Healthcare, Inc. (MOH) Q2 2026 Earnings Call Transcript
On July 23, 2026, Molina Healthcare Inc (MOH) shares fell 9.7%, closing at $200.29. This decline comes amid a broader context of price fluctuations, with the st
Molina beats Q2 earnings estimates as lower operating expenses offset weaker premium revenues, declining membership and softer investment income, while the company raises its 2026 earnings guidance.
The headline numbers for Molina (MOH) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Molina (MOH) came out with quarterly earnings of $1.51 per share, beating the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $5.48 per share a year ago.
LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported second quarter 2026 GAAP income per diluted share of $1.19 and adjusted income per diluted share of $1.51. Financial results are summarized below: Three months ended Six months ended June 30, June 30, 2026 2025 2026 2025 (In millions, except per-share results) Premium Revenue $10,244 $10,868 $20,416 $21,496 Total Revenue $10,874 $11,427 $2.
Beyond analysts' top-and-bottom-line estimates for Molina (MOH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.
NEW YORK, July 16, 2026 /PRNewswire/ -- S&P SmallCap 600 constituent Molina Healthcare Inc. (NYSE: MOH) will replace National Storage Affiliates Trust (NYSE: NSA) in the S&P MidCap 400, and Construction Partners Inc. (NASD: ROAD) will replace Molina Healthcare in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 22. S&P 500 constituent Public Storage (NYSE: PSA) is acquiring National Storage Affiliates Trust in a deal that is expected to be completed on or about that date pending final conditions.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Explore how portfolio size and sector exposure differ between these two small-cap ETFs, each offering unique advantages for investors.
Molina (MOH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Joel Greenblatt's Magic Formula ranks stocks on two factors: earnings yield (EBIT divided by enterprise value) and return on capital.